In diffuse large B-cell lymphoma (DLBCL), exosomal ENO2 enhances glycolytic metabolism, activating the GSK3β/β-catenin/c-Myc signaling pathway, which in turn promotes macrophage M2 polarization 22. Here, GSK3B is linked to diffuse large B-cell lymphoma.